We are live on
!
Find out more
FI
Focused Investors Portfolio holdings
AUM
$2.96B
1-Year Est. Return
15.6%
This Fund
S&P 500
This Quarter
Est. Return
+10.52%
1 Year Est. Return
+15.6%
3 Year Est. Return
+51.26%
5 Year Est. Return
+77.43%
10 Year Est. Return
+309.27%
AUM
$3.19B
AUM Growth
+$104M
(+3.4%)
Cap. Flow
-$182M
Cap. Flow
% of AUM
-5.71%
Top 10 Holdings %
Top 10 Hldgs %
57.69%
Holding
23
New
–
Increased
1
Reduced
22
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$10.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$32.9M |
| 2 |
Johnson & Johnson
JNJ
|
+$12.2M |
| 3 |
UnitedHealth
UNH
|
+$12M |
| 4 |
Cigna
CI
|
+$11.4M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$10.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.17% |
| 2 | Technology | 17.19% |
| 3 | Industrials | 16.88% |
| 4 | Consumer Discretionary | 13.91% |
| 5 | Financials | 12.95% |
Similar funds
SSM
VGM
CSIC
BCF
PHAM
SP
B
NC
Focused Investors's Q1 2024 Portfolio in Review
As of Q1 2024, Focused Investors held 23 positions worth $3.19B, up 3.4% from $3.09B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Focused Investors withdrew a net $182M in Q1 2024, reducing 22 holdings. Its largest reduction was Microsoft, cutting an estimated $32.9M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.
Against the trend, Focused Investors added an estimated $10.6M to Elevance Health.
- Focused Investors added most to Elevance Health in Q1 2024, an estimated $10.6M increase.
- Focused Investors's biggest Q1 2024 reduction was Microsoft, cutting an estimated $32.9M.
- Focused Investors's ten largest holdings make up 58% of its $3.19B portfolio in Q1 2024.
- Focused Investors opened 0 new positions and closed 0 in Q1 2024.
- Focused Investors's portfolio value rose 3.4% quarter-over-quarter to $3.19B.
Based on Focused Investors's 13F filing for Q1 2024, filed 25 Apr 2024.